M. Paula Aristizabal, MD, MAS
|
Title(s) | Associate Clinical Professor, Pediatrics |
---|
School | Vc-health Sciences-schools |
---|
Address | 9500 Gilman Drive # La Jolla CA 92093
|
---|
ORCID
.gif) | 0000-0003-0588-1532  |
---|
vCard | Download vCard |
---|
|
|
Biography
University of California San Francisco, CA | Certificate in Implementation Science | 6/2021 | |
Institute of Healthcare Improvement, Boston, MA | Certificate in Quality Improvement Coaching | 9/2019 | |
Rady Children's Hospital San Diego, San Diego, CA | Certificate in Quality Improvement Leadership | 6/2019 | |
University of Missouri, Children's Mercy Pediatric Bioethics Center, Kansas, MO | Certificate in Pediatric Bioethics | 5/2016 | |
University of California San Diego, La Jolla, CA | Masters of Advance Studies in Clinical Research | 6/2015 | |
University of California San Diego, La Jolla, CA | Fellowship in Pediatric Hematology/Oncology | 11/2013 | |
NIH | 2020 | | National Research Mentoring Network (NMRN) Grant Writing Training Program Scholar |
Colombian Academy of Medicine | 2020 | | National Academy of Medicine Research Award |
NCI | 2019 | | Center to Reduce Cancer Health Disparities National Minority Health Month Spotlight |
NIH | 2019 | | Entering Research Curriculum Train-the Trainer Scholar |
NIH/Johns Hopkins Bloomberg School of Public Health | 2019 | | Mixed Methods Research Training Program for the Health Sciences Scholar |
University of California San Diego | 2018 | | Hispanic Center of Excellence Faculty Scholar |
American Society of Hematology | 2018 | | Best Capacity-Building Project, Global Capacity-Building Showcase |
American Society of Hematology | 2017 | | Best Capacity-Building Project, Global Capacity-Building Showcase |
Mexican Consulate- San Diego | 2009
-
| 2011 | Recognition for Outstanding Leadership in the Mexico-U.S. border |
Government of Mexico | 2009
-
| 2011 | Recognition for Outstanding Leadership in Pediatric Oncology |
Overview
Dr. Paula Aristizabal is a pediatric hematologist-oncologist at Rady Children's Hospital-San Diego and an Associate Professor of Pediatrics in the Division of Pediatric Hematology/Oncology at UC San Diego. She completed her fellowship in pediatric hematology and oncology at UC San Diego and a Master of Advanced Studies in Clinical Research at UC San Diego.
Dr. Aristizabal research interests include ethics, patient-provider communication and global health, with a focus on discovering the causes of pediatric cancer disparities and developing strategies to improve outcomes in racial/ethnic minorities and underseved groups. Her work has focused on the barriers to participation in pediatric cancer clinical trials experienced by Hispanic children and how social determinants of health, such as race/ethnicity, socio-economic status, health literacy, language, and acculturation, affect outcomes in Hispanics. She has also conducted global health projects on implementation of health services for children with cancer in underserved areas in Latin America, including Mexico and Colombia, to improve access to care, cancer surveillance and registration, and cancer disparities globally.
Dr. Aristizabal is the principal investigator of several clinical research studies focused on implementation science, qualitative research, mixed methods, bioethics and quality improvement. She mentors trainees and junior faculty in diverse quality improvement and research projects, including medical students in their ISP projects.
She is a member of the UC San Diego Moores Cancer Center Population Sciences, Disparities and Community Engagement division, the San Diego Clinical and Translational Research Institute, and the UC San Diego Dissemination and Implementation Science Center.
In her clinical work, Dr. Aristizabal specializes in the care of children with leukemia and lymphoma. She is the Division's Quality Improvement Lead and chair of the Quality Improvement Committee.
ORNG Applications
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Improving Pediatric Neuro-Oncology Survival Disparities in the United States-Mexico Border Region: A Cross-Border Initiative Between San Diego, California, and Tijuana, Mexico. JCO Glob Oncol. 2020 11; 6:1791-1802.
Aristizabal P, Burns LP, Kumar NV, Perdomo BP, Rivera-Gomez R, Ornelas MA, Gonda D, Malicki D, Thornburg CD, Roberts W, Levy ML, Crawford JR. PMID: 33216645; PMCID: PMC7713516.
View in:
PubMed Mentions: Translation:
Humans
-
Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomized Clinical Trial. JAMA Netw Open. 2020 08 03; 3(8):e2014205.
Bhatia S, Hageman L, Chen Y, Wong FL, McQuaid EL, Duncan C, Mascarenhas L, Freyer D, Mba N, Aristizabal P, Walterhouse D, Lew G, Kempert PH, Russell TB, McNall-Knapp RY, Jacobs S, Dang H, Raetz E, Relling MV, Landier W. PMID: 32852553; PMCID: PMC7453312.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Diverse populations and enrollment in pediatric cancer clinical trials: Challenges and opportunities. Pediatr Blood Cancer. 2020 11; 67(11):e28296.
Aristizabal P. PMID: 32343877; PMCID: PMC8203427.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Sociodemographic and clinical characteristics associated with vitamin D status in newly diagnosed pediatric cancer patients. Pediatr Hematol Oncol. 2020 May; 37(4):314-325.
Aristizabal P, Sherer M, Perdomo BP, Castelao E, Thornburg CD, Proudfoot J, Jacobs E, Newfield RS, Zage P, Roberts W, Martinez ME. PMID: 32153233; PMCID: PMC7207243.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCTClinical Trials
-
Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance. J Pediatr Hematol Oncol. 2019 Nov; 41(8):e546-e549.
Paul MR, Wong V, Aristizabal P, Kuo DJ. PMID: 30807395; PMCID: PMC7216755.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Childhood cancer survival disparities in a universalized healthcare system. J Pediatr Hematol Oncol. 2018; 4(3):78-87.
Ramirez O, Aristizabal P, Zaidi A, Ribeiro RC, Bravo LE. 2019;3(4):78-87. doi.org/10.1016/j.phoj.2019.01.001.
-
The "Golden Hour": a capacity-building initiative to decrease life-threating complications related to neutropenic fever in patients with hematologic malignancies in low- and middle-income countries. Blood Adv. 2018 11 30; 2(Suppl 1):63-66.
Ornelas-Sánchez M, Nuño-Vázquez L, Loera-Reyna A, Torres-Reyes D, Rivera-Gómez R, Sánchez A, Romano M, González M, Caniza MA, Aristizabal P. PMID: 30504206; PMCID: PMC6438274.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Implementing a Childhood Cancer Outcomes Surveillance System Within a Population-Based Cancer Registry. J Glob Oncol. 2018 09; 4:1-11.
Ramirez O, Aristizabal P, Zaidi A, Ribeiro RC, Bravo LE, VIGICANCER Working Group. PMID: 30241253; PMCID: PMC6223468.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110.
Scheurer ME, Lupo PJ, Schüz J, Spector LG, Wiemels JL, Wiemels JL, Aplenc R, Gramatges MM, Schiffman JD, Pombo-de-Oliveira MS, Yang JJ, Heck JE, Metayer C, Orjuela-Grimm MA, Bona K, Aristizabal P, Austin MT, Rabin KR, Russell HV, Poplack DG. PMID: 29737912; PMCID: PMC6685736.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Medulloblastoma With Extensive Nodularity: Tailored Therapy in a Low-resource Setting. J Pediatr Hematol Oncol. 2017 05; 39(4):299-301.
Aristizabal P, Burns L, Rivera-Gomez R, Levy ML, Roberts W, Crawford JR. PMID: 28267079.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Addressing regional disparities in pediatric oncology: Results of a collaborative initiative across the Mexican-North American border. Pediatr Blood Cancer. 2017 06; 64(6).
Aristizabal P, Fuller S, Rivera-Gomez R, Ornelas M, Nuno L, Rodriguez-Galindo C, Ribeiro R, Roberts W. PMID: 28000395; PMCID: PMC5608088.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Factors associated with cervical cancer screening in a safety net population. World J Clin Oncol. 2016 Oct 10; 7(5):406-413.
Heberer MA, Komenaka IK, Nodora JN, Hsu CH, Gandhi SG, Welch LE, Bouton ME, Aristizabal P, Weiss BD, Martinez ME. PMID: 27777883; PMCID: PMC5056332.
View in:
PubMed Mentions:
3
-
The Centers for Disease Control and Prevention definition of mucosal barrier injury-associated bloodstream infection improves accurate detection of preventable bacteremia rates at a pediatric cancer center in a low- to middle-income country. Am J Infect Control. 2016 Apr 01; 44(4):432-7.
Torres D, González ML, Loera A, Aguilera M, Relyea G, Aristizabal P, Caniza MA. PMID: 26775931; PMCID: PMC4818654.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Factors associated with surgical management in an underinsured, safety net population. Surgery. 2016 Feb; 159(2):580-90.
Winton LM, Nodora JN, Martinez ME, Hsu CH, Djenic B, Bouton ME, Aristizabal P, Ferguson EM, Weiss BD, Komenaka IK. PMID: 26444326.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection. Hepatology. 2015 Oct; 62(4):1047-58.
Carlin AF, Aristizabal P, Song Q, Wang H, Paulson MS, Stamm LM, Schooley RT, Wyles DL. PMID: 26147061; PMCID: PMC4589477.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansCells
-
Improving Pediatric Cancer Care Disparities Across the United States-Mexico Border: Lessons Learned from a Transcultural Partnership between San Diego and Tijuana. Front Public Health. 2015; 3:159.
Aristizabal P, Fuller S, Rivera R, Beyda D, Ribeiro RC, Roberts W. PMID: 26157788; PMCID: PMC4476311.
View in:
PubMed Mentions:
4
-
Preoperative Presentation of a Variant of Cerebellar Mutism Syndrome in a Young Boy With Juvenile Pilocytic Astrocytoma. Pediatr Neurol. 2015 Sep; 53(3):266-7.
Chen DY, Aristizabal P, Crawford JR. PMID: 26145481.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities. Pediatr Blood Cancer. 2015 Aug; 62(8):1337-44.
Aristizabal P, Singer J, Cooper R, Wells KJ, Nodora J, Milburn M, Gahagan S, Schiff DE, Martinez ME. PMID: 25755225; PMCID: PMC4482802.
View in:
PubMed Mentions:
23 Fields:
Translation:
Humans
-
Descriptive epidemiology of childhood cancer in Cali: Colombia 1977-2011. Colomb Med (Cali). 2013 Jul; 44(3):155-64.
Bravo LE, García LS, Collazos P, Aristizabal P, Ramirez O. PMID: 24892613; PMCID: PMC4002030.
View in:
PubMed Mentions:
8 Fields:
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
Year | Publications |
---|
2013 | 1 |
2015 | 5 |
2016 | 3 |
2017 | 1 |
2018 | 4 |
2019 | 1 |
2020 | 4 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs